THE EFFECT OF ANTISENSE BCL-2 OLIGONUCLEOTIDES ON BCL-2 PROTEIN EXPRESSION AND APOPTOSIS IN HUMAN BLADDER TRANSITIONAL CELL CARCINOMA
- 1 September 2001
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 166 (3) , 1098-1105
- https://doi.org/10.1016/s0022-5347(05)65929-0
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Overexpression of Bcl-2 enhances metastatic potential of human bladder cancer cellsBritish Journal of Cancer, 1999
- Apoptosis and its clinical significance for bladder cancer therapyBJU International, 1999
- bcl-2/bax EXPRESSION AND p53 GENE STATUS IN HUMAN BLADDER CANCER: RELATIONSHIP TO EARLY RECURRENCE WITH INTRAVESICAL CHEMOTHERAPY AFTER RESECTIONJournal of Urology, 1998
- Overexpression of Bcl-2 in bladder cancer cells inhibits apoptosis induced by cisplatin and adenoviral-mediated p53 gene transferOncogene, 1998
- Bcl-2 and p53 Expressions in Invasive Bladder CancersActa Oncologica, 1998
- Apoptosis and chemotherapy resistanceEuropean Journal Of Cancer, 1996
- bcl-2/bax mRNA expression ratio as prognostic factor in low-grade urinary bladder cancerInternational Journal of Cancer, 1996
- Apparent Failure of Current Intravesical Chemotherapy Prophylaxis to Influence the Long-Term Course of Superficial Transitional Cell Carcinoma of the BladderJournal of Urology, 1995
- Apoptosis and cancer chemotherapyPhilosophical Transactions Of The Royal Society B-Biological Sciences, 1994
- Superficial Bladder Cancer: Progression and RecurrenceJournal of Urology, 1983